CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Ellogon AI develops advanced algorithms for analyzing tumor biopsy images to identify cancer biomarkers. Their technology aims to connect histopathology images with treatment outcomes, enhancing cancer diagnostics and predictions.
Ellogon AI is an innovative start-up established in 2019 as a spin-off from University of Amsterdam, by leading academic experts in artificial intelligence, medical imaging, and computational pathology.
The company develops a unique approach to analysis of complex histopathology images of tumour biopsies by directly connecting them to treatment outcomes.
The developed technology is based on self-learning algorithms able to analyse whole-slide image big data and with a near-perfect accuracy to id…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
